Insidermedicine Daily News (Video)
Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured ...
Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured by Google News and The News Room. April 25, 2007 Patients with HIV who are treated with protease inhibitors have an increased risk of heart attack, according to a study published in the New England Journal of Medicine. Combination antiretroviral therapy has had a dramatic effect in reducing illness and death associated with the HIV virus, however an earlier study showed that the risk of heart attacks increased by 17% with every year a patient spent on antiretroviral. It isn’t known, though, whether all antiretroviral drugs carry this risk. The assessment of the role of any specific drug is difficult because patients with HIV usually receive a combination of drugs, and often switch regimens because of the availability of newer substances, adverse events, or drug regimen failure. Previous studies have shown a relationship between the use of protease inhibitors, a class of antiretroviral drug, and cardiovascular disease, but there is little information on the risks associated with another class of antiretroviral therapy called nonnucleoside reverse-transcriptase inhibitors. In this study, more than 23,000 patients infected with the HIV virus were assessed to determine the incidence of heart attack and the association between heart attack and exposure to protease inhibitors or nonnucleoside reverse-transcriptase inhibitors. Confirming the earlier results, the researchers found the risk of having a heart attack increased by 16% per year of exposure to protease inhibitors alone, which is equal to twice the risk over five years. Not such effect was observed with nonnucleoside reverse-transcriptase inhibitors. It is thought that protease inhibitors raise the level of blood lipid, thereby increasing the risk of cardiovascular disease and heart attack. Patients treated with protease inhibitors should have their cholesterol and blood pressure levels monitored, and take steps to reduce their lifestyle-related risk factors. This includes maintaining a healthy weight, eating a low-fat diet rich in fruits in vegetables, and getting regular exercise. Reporting for Insidermedicine, I'm Dr. Susan Sharma.
Show all Visit Show Website http://www.insidermedicine.caRecently Aired
-
HD
Mental health problems after giving birth frequently linked to domestic violence
(May 30, 2013 - Insidermedicine) From London - Women with ...
(May 30, 2013 - Insidermedicine) From London - Women with mental health problems when they give birth are more likely to have previously experienced domestic violence, according to a report published PLOS Medicine. Researchers reviewed data from nearly 70 relevant studies. They found that as many as 13% of postnatal depression cases were connected to experiencing domestic violence during pregnancy. Women with both antenatal and postnatal depression were 3x more likely to have experienced domestic violence in the previous 12 months, and 5x more likely to experience this violence during pregnancy.
-
HD
Smoking cessation meds are effective
(May 30, 2013 - Insidermedicine) From Oxford - A new ...
(May 30, 2013 - Insidermedicine) From Oxford - A new report published in the Cochrane Library finds that licensed smoking cessation medications are indeed effective. Researchers reviewed data from nearly 300 studies comprised of over 100,000 people. These studies examined the effectiveness of both licensed and unlicensed smoking cessation medications. A successful attempt at quitting smoking was defined as six months or longer. Results showed that the three widely used medications--nicotine replacement therapies, bupropion, and varenicline--all improved a smokers chance of quitting. Compared to the placebo, the odds of quitting were 80% higher for those taking NRT or bupropion, and 2-3x higher for those taking varenicline.
-
HD
Lucentis improves reading speed in patients with retinal vein occlusion
(May 29, 2013 - Insidermedicine) From Florida - A new ...
(May 29, 2013 - Insidermedicine) From Florida - A new report published in JAMA Ophthalmology examines reading speed outcomes in individuals with retinal vein occlusion treated with Lucentis. Researchers studied nearly 800 patients suffering from macular edema after branch retinal vein occlusion or central retinal vein occlusion. Participants were randomized to monthly sham injections, monthly ranibizumab 0.3 or monthly ranibizumab 0.5 mg. Researchers then assessed reading speed in the participants at 1,3 and 6 months post-injection. Results showed that individuals treated with ranibizumab were more likely to demonstrate reading speed improvements at 6 months than those who received sham injections.
-
HD
Weed killers, pesticides linked to Parkinson's disease
(May 28, 2013 - Insidermedicine) From Italy - According to ...
(May 28, 2013 - Insidermedicine) From Italy - According to research published in Neurology, exposure to pesticides and weed killers may raise risk of Parkinson's disease. Researchers conducted a meta-analysis of 104 studies examining the effect of exposure to weed, fungus, rodent/bug killers, and solvents on the development Parkinson's disease. These studies examined aspects such as country living, occupation, and well water drinking. Results showed that exposure to bug or weed killers and solvents raised risk of Parkinson's disease by as much as 80%. As well, researchers found that exposure to paraquat (a weed killer) or the fungicides maneb and mancozeb raised risk twofold.
-
HD
Ranibizumab improves visual acuity in diabetic macular edema patients
(May 28, 2013 - Insidermedicine) From Houston - Ranibizumab for ...
(May 28, 2013 - Insidermedicine) From Houston - Ranibizumab for diabetic macular edema greatly benefits visual acuity, according to a new report published in Ophthalmology. Researchers studied nearly 800 DME patients, randomizing participants to either monthly ranibizumab injections or sham injections with cross-over to ranibizumab injections after 1 year. Participants had their visual acuity measured at 24 and 36 months. Results showed that patients treated with ranibizumab demonstrated much greater improvements in their visual acuity than those who received the delayed ranibizumab
-
HD
Increase in accidental marijuana consumption among kids
(May 28, 2013 - Insidermedicine) From Colorado - A new ...
(May 28, 2013 - Insidermedicine) From Colorado - A new report published in JAMA Pediatrics finds an increase in accidental ingestion of marijuana-laced foods among children. Researchers studied nearly 1,400 children under 12 years of age, all of whom were evaluated for accidental ingestions. Nearly 800 patients were seen prior to September 2009--before Colorado's drug laws started relaxing--while nearly 600 were seen after October 1, 2009. Results showed that 0 children were seen for accidental marijuana ingestion prior to Sept. 2009, while 14 were seen after October 1. Eight of these patients had directly consumed food containing marijuana
-
HD
Women taking daily calcium supplements have longer lifespan
(May 27, 2013 - Insidermedicine) From Montreal - Women taking ...
(May 27, 2013 - Insidermedicine) From Montreal - Women taking daily calcium supplements may live longer, according to a report published in the Journal of Clinical Endocrinology and Metabolism. Resarchers studied over 9,000 adults from 1995-2007. During this period, there were over 1,000 deaths. Results showed that women who took daily calcium supplements had longer lifespan, though there was no such benefit for men.
-
HD
Schizophrenia symptoms eliminated in a mouse model
(May 23, 2013 - Insidermedicine) From Georgia - Scientists have ...
(May 23, 2013 - Insidermedicine) From Georgia - Scientists have eliminated schizophrenia symptoms in a mouse model, according to a report published in Neuron. Researchers genetically altered mice to develop overexpression of a gene known to be associated with schizophrenia. When this gene was elevated, the mice were hyperactive, could not retain things they had just learned, and could not ignore background noise. When researchers returned the gene's levels to normal, the rodents no longer demonstrated these symptoms.
-
HD
Children exposed to secondhand smoke are more aggressive at age 10
(May 23, 2013 - Insidermedicine) From Montreal - Children exposed ...
(May 23, 2013 - Insidermedicine) From Montreal - Children exposed to secondhand smoke are more likely to demonstrate aggressive behaviour, according to a report published in the Journal of Epidemiology and Community Health. Researchers studied over 2,000 children who were tracked from birth until the age of 10, examining parents reports on secondhand smoke exposure at home as well as reports on classroom behavior from teachers and the children themselves. Results showed that those exposed to secondhand smoke, even just temporarily, were much more likely to demonstrate antisocial and aggressive behavior at the age of 10. These results were consistent even after accounting for smoke exposure during pregnancy and the parent's behavioural problems.
-
HD
Tonsil surgery improves sleep in children with sleep apnea
(May 22, 2013 - Insidermedicine) From Maryland - Tonsil surgery ...
(May 22, 2013 - Insidermedicine) From Maryland - Tonsil surgery can improve sleep in children w ith sleep apnea, according to a report published in the NEJM. Researchers randomized 464 children with obstructive sleep apnea to receive adenoid and tonsil surgery or supportive medical care and observation. Psychological testing revealed no cognitive differences between the two groups. Children who underwent surgery had better sleep quality, behavioural regulation and quality of life when compared to those who received treatment and observation. Nearly 80% of the surgery patients saw their sleep apnea resolved after seven months, compared to just 46% of those in the observation group.
